MedPath

Endometrial Cancer Diet and Exercise

Not Applicable
Completed
Conditions
Early Stage Endometrial Cancer
Interventions
Behavioral: Home-based aerobic exercise and nutritional counseling
Registration Number
NCT02987881
Lead Sponsor
Duke University
Brief Summary

This study will evaluate whether the use of the Jawbone wristband monitor, in connection with home-based exercise and nutritional counseling can be safely completed and improve cardiorespiratory fitness (heart and lung health) in women with early stage endometrial cancer who have undergone surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
16
Inclusion Criteria
  • Ages > 18 years.
  • Localized endometrial cancer (stage I and II); no evidence of stage III or IV disease.
  • At least 2 months was passed since the hysterectomy and enrollment.
  • Karnofsky performance status > 70%.
  • Body mass index of 30.0 - 49.9 and body weight < 300 pounds.
  • No plan for adjuvant endometrial cancer therapy.
  • Able to exercise safely on a treadmill.
  • No absolute contraindications to exercise testing as recommended by the American Thoracic Society. No recent (<6 months) acute cardiac event unstable angina, uncontrolled dysrhythmias causing symptoms or hemodynamic compromise, symptomatic aortic stenosis, uncontrolled symptomatic heart failure, acute pulmonary embolus, acute myocarditis or pericarditis, suspected or known dissecting aneurism and acute systemic infection.
  • The subject is not participating in regular physical exercise (more than 60 minutes of moderate intensity or 30 minutes of vigorous intensity exercise per week) or weight reduction dieting.
  • Able to provide informed consent.
  • Have reliable transportation to the testing facilities.
  • Subjects must be able to speak and understand English to participate in this study.
  • Subjects must have a personal mobile device compatible for the activity monitor

Compatible devices for the activity monitors are below:

  • Android

    o Activity monitor is compatible with most Android devices equipped with Bluetooth 4.0 and running Android 4.3 (Jelly Bean) or later.

  • iOS

    • iPhone 4s (or newer)
    • iPod touch (5th generation or newer)
    • iPad (3rd generation or newer)
    • iPad mini (1st generation or newer)
    • iPad Air (1st generation or newer)
Read More
Exclusion Criteria
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Adult women with early stage localized endometrial cancerHome-based aerobic exercise and nutritional counselingAdult women with early stage localized endometrial cancer at least 2 months following hysterectomy
Primary Outcome Measures
NameTimeMethod
Feasibility as measured by adherence to weekly walking sessionsWeek 12

Percentage of daily steps divided by total number of steps and daily walking sessions divided by total number of sessions prescribed

Safety as measured by the type and prevalence of adverse events during study-related assessmentsWeek 12

Collection of events related to cardiopulmonary testing and self-reported events during off-site exercise training

change in cardiorespiratory fitness and CVD risk profile as measured by lipid profilebaseline and 12 weeks
change in cardiorespiratory fitness and CVD risk profile as measured by blood pressurebaseline and 12 weeks
change in cardiorespiratory fitness and CVD risk profile as measured by VO2peakbaseline and 12 weeks
change in cardiorespiratory fitness and CVD risk profile as measured by C-reactive proteinbaseline and 12 weeks
change in cardiorespiratory fitness and CVD risk profile as measured by body compositionbaseline and 12 weeks
Secondary Outcome Measures
NameTimeMethod
patient experience with exercise and nutrition counseling as measured by telephone questionnaire16 weeks

Trial Locations

Locations (1)

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath